These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34862610)

  • 21. Predicting short-term and long-term mortality of hospitalized Portuguese patients with alcoholic hepatitis.
    Fernandes SR; Marques da Costa P; Vítor S; Carvalho JR; Santos P; Moura CM; Cortez-Pinto H; Ramalho F; Velosa J
    Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1141-1148. PubMed ID: 28628497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MELD accurately predicts mortality in patients with alcoholic hepatitis.
    Dunn W; Jamil LH; Brown LS; Wiesner RH; Kim WR; Menon KV; Malinchoc M; Kamath PS; Shah V
    Hepatology; 2005 Feb; 41(2):353-8. PubMed ID: 15660383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of candidate gene variants in modulating the risk and severity of alcoholic hepatitis.
    Beaudoin JJ; Liang T; Tang Q; Banini BA; Shah VH; Sanyal AJ; Chalasani NP; Gawrieh S
    Alcohol Clin Exp Res; 2021 Apr; 45(4):709-719. PubMed ID: 33616244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis.
    Sehrawat TS; Arab JP; Liu M; Amrollahi P; Wan M; Fan J; Nakao Y; Pose E; Navarro-Corcuera A; Dasgupta D; Liao CY; He L; Mauer AS; Avitabile E; Ventura-Cots M; Bataller RA; Sanyal AJ; Chalasani NP; Heimbach JK; Watt KD; Gores GJ; Gines P; Kamath PS; Simonetto DA; Hu TY; Shah VH; Malhi H
    Hepatology; 2021 Feb; 73(2):571-585. PubMed ID: 32246544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease?
    Kanwal F; Hays RD; Kilbourne AM; Dulai GS; Gralnek IM
    Am J Gastroenterol; 2004 Sep; 99(9):1726-32. PubMed ID: 15330910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis.
    Forrest EH; Atkinson SR; Richardson P; Masson S; Ryder S; Thursz MR; Allison M;
    J Hepatol; 2018 Mar; 68(3):511-518. PubMed ID: 29175535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of MELD score and Maddrey discriminant function for mortality prediction in patients with alcoholic hepatitis.
    Monsanto P; Almeida N; Lrias C; Pina JE; Sofia C
    Hepatogastroenterology; 2013; 60(125):1089-94. PubMed ID: 23803373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers of Macrophage Activation and Immune Danger Signals Predict Clinical Outcomes in Alcoholic Hepatitis.
    Saha B; Tornai D; Kodys K; Adejumo A; Lowe P; McClain C; Mitchell M; McCullough A; Dasarathy S; Kroll-Desrosiers A; Barton B; Radaeva S; Szabo G
    Hepatology; 2019 Oct; 70(4):1134-1149. PubMed ID: 30891779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of patients with alcohol-associated hepatitis and acute kidney injury - Results from the HRS Harmony Consortium.
    Ma AT; Allegretti AS; Cullaro G; Ouyang T; Asrani SK; Chung RT; Przybyszewski EM; Wilechansky RM; Robinson JE; Sharma P; Simonetto DA; Jalal P; Orman ES; Wadei HM; St Hillien SA; Saly D; Ufere NN; Dageforde LA; Regner KR; Belcher JM; Patidar KR;
    Aliment Pharmacol Ther; 2024 Sep; 60(6):778-786. PubMed ID: 39010302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effects of as-Needed Nalmefene on Patient-Reported Outcomes and Quality of Life in Relation to a Reduction in Alcohol Consumption in Alcohol-Dependent Patients.
    François C; Rahhali N; Chalem Y; Sørensen P; Luquiens A; Aubin HJ
    PLoS One; 2015; 10(6):e0129289. PubMed ID: 26053024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting Low Risk for Sustained Alcohol Use After Early Liver Transplant for Acute Alcoholic Hepatitis: The Sustained Alcohol Use Post-Liver Transplant Score.
    Lee BP; Vittinghoff E; Hsu C; Han H; Therapondos G; Fix OK; Victor DW; Dronamraju D; Im GY; Voigt MD; Rice JP; Lucey MR; Eswaran S; Chen PH; Li Z; Maddur H; Terrault NA
    Hepatology; 2019 Apr; 69(4):1477-1487. PubMed ID: 30561766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis.
    Louvet A; Labreuche J; Artru F; Boursier J; Kim DJ; O'Grady J; Trépo E; Nahon P; Ganne-Carrié N; Naveau S; Diaz E; Gustot T; Lassailly G; Cannesson-Leroy A; Canva-Delcambre V; Dharancy S; Park SH; Moreno C; Morgan TR; Duhamel A; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):398-406.e8; quiz e16-7. PubMed ID: 25935634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort.
    Papastergiou V; Tsochatzis EA; Pieri G; Thalassinos E; Dhar A; Bruno S; Karatapanis S; Luong TV; O'Beirne J; Patch D; Thorburn D; Burroughs AK
    Aliment Pharmacol Ther; 2014 Apr; 39(7):721-32. PubMed ID: 24612165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of gastrointestinal hemorrhage and prediction of mortality in Asian patients with alcoholic hepatitis.
    Kim SH; Kim BG; Kim W; Oh S; Kim HY; Jung YJ; Jeong JB; Kim JW; Lee KL
    J Gastroenterol Hepatol; 2016 Apr; 31(4):814-21. PubMed ID: 26513408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A return to harmful alcohol consumption impacts on portal hemodynamic changes following alcoholic hepatitis.
    Spahr L; Goossens N; Furrer F; Dupuis M; Vijgen S; Elkrief L; Giostra E; Rubbia-Brandt L; Frossard JL
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):967-974. PubMed ID: 29727387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of septic events, type 1 hepatorenal syndrome, and mortality in severe alcoholic hepatitis and utility of discriminant function and MELD score in predicting these adverse events.
    Verma S; Ajudia K; Mendler M; Redeker A
    Dig Dis Sci; 2006 Sep; 51(9):1637-43. PubMed ID: 16927139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis.
    Arab JP; Sehrawat TS; Simonetto DA; Verma VK; Feng D; Tang T; Dreyer K; Yan X; Daley WL; Sanyal A; Chalasani N; Radaeva S; Yang L; Vargas H; Ibacache M; Gao B; Gores GJ; Malhi H; Kamath PS; Shah VH
    Hepatology; 2020 Aug; 72(2):441-453. PubMed ID: 31774566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis.
    Díaz LA; Fuentes-López E; Ayares G; Idalsoaga F; Arnold J; Valverde MA; Perez D; Gómez J; Escarate R; Villalón A; Ramírez CA; Hernandez-Tejero M; Zhang W; Qian S; Simonetto DA; Ahn JC; Buryska S; Dunn W; Mehta H; Agrawal R; Cabezas J; García-Carrera I; Cuyàs B; Poca M; Soriano G; Sarin SK; Maiwall R; Jalal PK; Abdulsada S; Higuera-de-la-Tijera F; Kulkarni AV; Rao PN; Salazar PG; Skladaný L; Bystrianska N; Clemente-Sanchez A; Villaseca-Gómez C; Haider T; Chacko KR; Romero GA; Pollarsky FD; Restrepo JC; Castro-Sanchez S; Toro LG; Yaquich P; Mendizabal M; Garrido ML; Marciano S; Dirchwolf M; Vargas V; Jiménez C; Louvet A; García-Tsao G; Roblero JP; Abraldes JG; Shah VH; Kamath PS; Arrese M; Singal AK; Bataller R; Arab JP
    JHEP Rep; 2023 Aug; 5(8):100727. PubMed ID: 37456675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rising Trend in Waitlisting for Alcoholic Hepatitis With More Favorable Outcomes Than Other High Model for End-stage Liver Disease in the Current Era.
    Bittermann T; Mahmud N; Weinberg EM; Reddy KR
    Transplantation; 2022 Jul; 106(7):1401-1410. PubMed ID: 35349533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma-Signature-Model for End-Stage Liver Disease Score to Predict Survival in Severe Alcoholic Hepatitis.
    Fujiwara N; Trépo E; Raman I; Li QZ; Degré D; Gustot T; Moreno C; Hoshida Y
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):651-657. PubMed ID: 33667676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.